Psychiatriatric Children and Youth Hospital
Esbjerg, Denmark
NCT Number: NCT07314515
In this project, a 10-session treatment program was developed aimed at young people who experience voice hearing. The treatment has potential to easily be implemented in everyday clinical practice in Child and Adolescent Psychiatry, and eventually in Educational Psychological Counselling (PPR) and the newly established STIME services (low-threshold municipal treatment offers for children and young people).
As part of the treatment, the young person's caregivers are involved. This means a high degree of involvement from adults who know the young person well and are part of their daily life.
In addition to traditional Compassion-focuced therapy (CFT), the treatment is expanded with an intervention where an audio file is recorded with content corresponding to the adolescent's voice hearing. The parents are invited to listen to the audio file while participating in a therapy session. This will help improve the caregivers understanding of the young person's experiences and challenges.
Trial opening soon.
Get Notified13 year–21 year
All sexes
Interventional
Not applicable
Esbjerg, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A manualized 10 session, intervention inspired by compassion focused therapy. A primary caretaker paticipates in 5 sessions.
Other names: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up.
Psychotic symptoms are measured with: BAVQ-R (Beliefs about Voices Questionnaire - Revised) (Chadwick et al., 2000).( 35 items are rated (0-3) total minimum score 0, maximum score 105. Some scores indicate higher distress, while other indicate lower distress).
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up.
PSYRATS AH (Psychotic Symptoms Rating Scale Auditory Hallucinations) (Haddock et al., 1999). (11 items are rated (0-4) total minimum score 0, maximum score 44. Higher score being more severe)
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up.
The Yale Control Over Perceptual Experiences (COPE) Scales measures voluntary control over voices such as being able to intentionally influence the timing, frequency, or intensity of voice hearing experiences (Mourgues et al., 2022). (36 items are rated (1-7) total minimum score 36, maximum score 252. Higher scores indicate stronger perceived control over voices)
Time frame: Social cognition is tested 3 months before treatment and right after
Social cognition is tested with TASIT 2A DK (The Awareness of Social Inference Test) (McDonald et al., 2003). (60 items are rated, minimum total score 0, maximum score is 60. Lower score being more severe)
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up
SSPS (Social safeness and pleasure scale) (Gilbert et al., 2009). (11 items are rated (1-5). Total minimum 11, total maximum 55. Lower score being more severe).
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up
SCS-SF (Self-Compassion Scale Short Form) (Raes et al., 2011; Neff et al., 2019) (12 items are rated (1-5) total minimum 12, total maximum 60. Lower score being more severe).
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up
The Social Connectedness Scale Revised (Lee et al., 1995; Sabitelli et al., 2005). (8 items are rated (1-6). Total minimum score 8, total maximum score 48. Lower score being more severe).
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up
MSPSS (The Multidimensional Scale of Perceived Social Support) (Zimet et al. 1988).(12 items are rated (1-7) total minimum 12, total maximum 84. Lower score being more severe).
Time frame: Before treatment
Factual information about the young person: Education, cohabiting or divorced parents, the young person's residence, family history of mental illness, diagnosis and medication of the young person
Time frame: Data is collected 3 months prior to CFT treatment, immediately before the start of treatment, immediately after treatment is completed, and at 1 month follow-up
Additionally, questions are asked about how well you feel your parents understand you (e.g., do they know what motivates you and what scares you?) (Likert scale 1-10). Questions about daily stress, sleep, violence and abuse, well-being and quality of life, interaction with family and friends (from the "How are you?" survey among youth in the Central Denmark Region). Quality of life is measured with WHO-5.
Contact information is provided by the study sponsor or research team.
Maja K Musaeus, Psychologist
CONTACT
Vibeke F Bliksted, Professor
CONTACT
University of Southern Denmark
Other
Acronym: ECHO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07694193
Behavior, Hallucinations
Bron, France
View Trial DetailsNCT07555275
Behavior, Hallucinations
West Los Angeles, California, United States
View Trial DetailsNCT06938997
Hallucinations, Hallucinations, Auditory
Hualien City, Taiwan
View Trial DetailsNCT04798131
Hallucinations, Hallucinations, Auditory
Lille, France
View Trial Details